National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

indium In 111-labeled autologous polymorphonuclear leukocytes
A preparation of autologous peripheral polymorphonuclear (PMNLs) radiolabeled with indium In 111 with radioisoptoic activity. Autologous PMNLs are isolated, expanded ex vivo, radiolabeled with indium In 111, and then infused back into the patient. Gamma scintigraphy may then be used to image gamma ray-emitting indium In 111 PMNLs localized in lymhoma tissue. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:indium In 111-labeled autologous PMNLs



Previous:indium In 111 monoclonal antibody BrE-3, indium In 111 monoclonal antibody huPAM4, indium In 111 pentetate, indium In 111-CMD-193, indium In 111-labeled autologous peripheral blood mononuclear cells
Next:Indocin, indocyanine green solution, indole-3-carbinol, indomethacin, Infergen

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov